MedTrace Logo

Initial Local Anesthetic Dose With Continuous Interscalene Analgesia

NCT00672100 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2017-03-07

Study results available
· View outcomes & findings →

Summary

Objective: To determine a minimally effective initial local anesthetic bolus required to provide satisfactory analgesia using continuous brachial plexus infusion following arthroscopic shoulder surgery using a double-blind, randomized, study comparing 3 initial doses.

Conditions

  • Post-operative Pain

Interventions

DRUG

Ropivacaine

Initial Bolus 5 ml Ropivacaine via interscalene injection

DRUG

Ropivacaine

Initial Bolus 10 ml Ropivacaine via interscalene injection

DRUG

Ropivacaine

Initial Bolus 20 ml Ropivacaine via interscalene injection

Sponsors & Collaborators

  • Beaumont Foundation of America

    collaborator OTHER

  • William Beaumont Hospitals

    lead OTHER

Principal Investigators

  • Craig Hartrick, MD · William Beaumont Hospitals

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2010-02-28
Completion
2010-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00672100 on ClinicalTrials.gov